NZ185641A - Heterocyclic oxygen-containing compounds and pharmaceutical compositions - Google Patents

Heterocyclic oxygen-containing compounds and pharmaceutical compositions

Info

Publication number
NZ185641A
NZ185641A NZ185641A NZ18564177A NZ185641A NZ 185641 A NZ185641 A NZ 185641A NZ 185641 A NZ185641 A NZ 185641A NZ 18564177 A NZ18564177 A NZ 18564177A NZ 185641 A NZ185641 A NZ 185641A
Authority
NZ
New Zealand
Prior art keywords
methyl
nonenyl
dimethyl
oxo
compound
Prior art date
Application number
NZ185641A
Other languages
English (en)
Inventor
R Kanojia
M Wachter
R Chen
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NZ185641A publication Critical patent/NZ185641A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/04Seven-membered rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ185641A 1976-11-18 1977-11-08 Heterocyclic oxygen-containing compounds and pharmaceutical compositions NZ185641A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/742,940 US4102895A (en) 1976-11-18 1976-11-18 Oxepanes

Publications (1)

Publication Number Publication Date
NZ185641A true NZ185641A (en) 1984-08-24

Family

ID=24986860

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ185641A NZ185641A (en) 1976-11-18 1977-11-08 Heterocyclic oxygen-containing compounds and pharmaceutical compositions

Country Status (15)

Country Link
US (1) US4102895A (oth)
JP (1) JPS5365890A (oth)
AT (1) AT363478B (oth)
AU (1) AU516476B2 (oth)
CA (1) CA1113478A (oth)
CH (3) CH627469A5 (oth)
DE (1) DE2751396A1 (oth)
FR (1) FR2371443A1 (oth)
GB (1) GB1594100A (oth)
GR (1) GR63241B (oth)
IE (1) IE45915B1 (oth)
IL (1) IL53420A (oth)
NZ (1) NZ185641A (oth)
PH (1) PH13596A (oth)
ZA (1) ZA776879B (oth)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182717A (en) * 1978-06-29 1980-01-08 Ortho Pharmaceutical Corp. Total synthesis of the utero-evacuant substance d,l-zoapatanol
US4177194A (en) * 1978-06-29 1979-12-04 Ortho Pharmaceutical Corporation Total synthesis of the utero-evacuant substance D,L-zoapatanol
US4256644A (en) * 1978-12-18 1981-03-17 Ortho Pharmaceutical Corporation Chemical intermediates in the preparation of oxepane compounds
US4215048A (en) * 1979-05-18 1980-07-29 Ortho Pharmaceutical Corporation Total synthesis of (1RS, 4SR, 5RS)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4237054A (en) * 1979-05-18 1980-12-02 Ortho Pharmaceutical Corporation Total synthesis of (1RS,4SR,5RS)-4-(4,8-dimethyl-5-hydroxy-7-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1] octane-1-acetic acid
US4237055A (en) * 1979-06-18 1980-12-02 Ortho Pharmaceutical Corporation Synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4322353A (en) * 1980-04-18 1982-03-30 Ortho Pharmaceutical Corporation Synthesis of dioxabicyclo(3.2.1)octanes and oxepanes
US4284565A (en) * 1980-05-02 1981-08-18 Ortho Pharmaceutical Corporation Total synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl)-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid and related compounds
US4329288A (en) * 1980-05-02 1982-05-11 Ortho Pharmaceutical Corporation (1RS,4SR,5RS)-4-(5-Hydroxy-4,8-dimethyl-8-nonenyl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
KR850000218B1 (ko) * 1980-07-31 1985-03-06 오오소오 화아마슈이티갈 코오포레이숀 디옥사비시클로[3.2.1]옥탄 유도체의 합성방법
US4277401A (en) * 1980-08-25 1981-07-07 Ortho Pharmaceutical Corporation Total synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl)-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4307019A (en) * 1980-08-25 1981-12-22 Ortho Pharmaceutical Corporation Total synthesis of 1RS,4SR,5RS,-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid
US4322357A (en) * 1981-02-23 1982-03-30 Ortho Pharmaceutical Corporation Novel cycloheptanes
US4360467A (en) * 1981-02-23 1982-11-23 Ortho Pharmaceutical Corporation Process for preparing 8-oxabicyclo[3.2.1]-octane-1-acetic acids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515670C2 (de) * 1975-04-10 1985-07-25 Ortho Pharmaceutical Corp., Raritan, N.J. Verfahren zum Isolieren von Substanzen mit uteroevakuierender Wirkung aus der Zoapatl-Pflanze und diese Substanzen enthaltende Arzneimittel

Also Published As

Publication number Publication date
US4102895A (en) 1978-07-25
DE2751396A1 (de) 1978-05-24
IE45915L (en) 1978-05-18
CH627469A5 (fr) 1982-01-15
FR2371443A1 (fr) 1978-06-16
CH629792A5 (fr) 1982-05-14
JPS5365890A (en) 1978-06-12
JPS625154B2 (oth) 1987-02-03
ATA824077A (de) 1981-01-15
AU3072977A (en) 1979-05-24
AU516476B2 (en) 1981-06-04
CA1113478A (en) 1981-12-01
CH629793A5 (fr) 1982-05-14
GB1594100A (en) 1981-07-30
ZA776879B (en) 1979-06-27
FR2371443B1 (oth) 1984-02-24
AT363478B (de) 1981-08-10
GR63241B (en) 1979-10-12
IE45915B1 (en) 1982-12-29
IL53420A0 (en) 1978-01-31
PH13596A (en) 1980-08-05
IL53420A (en) 1983-05-15

Similar Documents

Publication Publication Date Title
NZ185641A (en) Heterocyclic oxygen-containing compounds and pharmaceutical compositions
Kwon et al. Synthesis and in vitro cytotoxicity of cinnamaldehydes to human solid tumor cells
FI71929B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara etrfoereningar samt vid deras framstaellning anvaendbara me llnprodukter
EP0013607B1 (en) Substituted bicyclo (2,2,1)heptanes and bicyclo (2,2,1) hept-2-enes and their pharmaceutical compositions
EP0104468B1 (en) Arachidonic acid analogues as anti-inflammatory and antiallergic agents
US4256659A (en) Method of preparing 2-aryl-1,3-cyclohexanedione compounds
HU197875B (en) Process for producing polycyclic aromatic amino-alcanol derivatives and pharmaceutical compositions containing themas active components
JPH0576447B2 (oth)
JPH0152375B2 (oth)
US5508412A (en) Phthalimides useful as intermediate compounds
US5268386A (en) Certain 3,4-dihydro 4-oxospiro [2H-1 benzopyrans] useful for treating hyperuricemia
JPS61263943A (ja) 5−リポキシゲナ−ゼ阻害剤としての2−置換−1−ナフト−ル類
Witiak et al. Synthesis of ethyl 6-substituted-chroman-and-chromone-2-carboxylates. Comparative structure-activity study employing the 6-phenyl and phenoxy analogs in the triton hyperlipidemic rat model
AU597324B2 (en) Indole derivatives, processes for their preparation and pharmaceutical compositions containing them
Ujvary et al. Insecticidal activity of various 3-acyl and other derivatives of veracevine relative to the Veratrum alkaloids veratridine and cevadine
WO1980001382A1 (en) Substituted (2,2,1) heptanes and hept-2-enes and their pharmaceutical compositions as inhibitors of thromboxane activity
US4176188A (en) Utero-evacuants
AU688965B2 (en) New O-arylmethyl-N-(thio)acylhydroxylamines, process for preparing them and pharmaceutical compositions containing them
Hassner et al. Alkylation and aldol reactions of aldoxime anions
Ando et al. Studies on the synthesis of sesquiterpene lactones, 14. Syntheses of (-)-arbusclin D and (+)-4-EPI-arbusclin D: the stereochemical assignment of arbusclin D
US4054439A (en) Acetal derivatives of 4-(substituted amino)-3,5-dinitrobenzaldehydes
AU634286B2 (en) Additional further novel alkanophenones
Voaden Some (E)-1, 4-Alkadiene Derivatives and the Synthesis of 5-(3E, 6-Heptadienyl) Dihydro-2 (3H)-Furanone
US3836542A (en) Derivatives of hydroxybenzo(b)thiophene
JPS6248639A (ja) 薬剤化合物